Researchers: Xiulin Tian, Mengxiong Pan, Mengting Zhou, Qiaomin Tang, Miao Chen, Wenwu Hong, Fangling Zhao, Kaiming Liu
Sarcopenia is defined as the age-related loss of muscle mass and function that can lead to prolonged hospital stays and decreased independence. It is a significant health and financial burden for individuals, families, and society as a whole. The accumulation of damaged mitochondria in skeletal muscle contributes to the degeneration of muscles with age. Currently, the treatment of sarcopenia is limited to improving nutrition and physical activity. Studying effective methods to alleviate and treat sarcopenia to improve the quality of life and lifespan of older people is a growing area of interest in geriatric medicine. Therapies targeting mitochondria and restoring mitochondrial function are promising treatment strategies. This article provides an overview of stem cell transplantation for sarcopenia, including the mitochondrial delivery pathway and the protective role of stem cells. It also highlights recent advances in preclinical and clinical research on sarcopenia and presents a new treatment method involving stem cell-derived mitochondrial transplantation, outlining its advantages and challenges.
References
- Exercise and mitochondrial mechanisms in patients with sarcopenia.
- The mechanisms and treatments for sarcopenia: could exosomes be a perspective research strategy in the future?
- Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities.
- The hallmarks of aging.
- Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice.